St. Jude Medical announced the completion of its acquisition of the privately held CardioMEMS Inc., developer of the CardioMEMS heart failure (HF) management system. The acquisition was completed on May 30, 2014.

As more endovascular medical programs adapt simulation as an essential part of their training curriculum, there is a constant and consistent need for updated simulation solutions. Simbionix is offering two new platforms and two training modules, to enhance hands-on training for more clinicians to enhance patient safety and improve clinical outcomes.

June St. Jude Medical Inc. announced preliminary results from the EnligHTN III study, which found the company’s second-generation EnligHTN renal denervation system provided safe and effective therapy for patients with drug-resistant, uncontrolled hypertension six months post-procedure. 

MedInformatix announced at the annual meeting of the Society for Imaging Informatics in Medicine (SIIM) that it is bringing its next-generation technology to clients using its provider and patient portal applications integrated with OneDX software.


New research has found that bariatric surgery is an effective way to control weight in morbidly obese patients who are at risk for developing atrial fibrillation (AF). Bariatric or weight loss surgery is an operation on the stomach that limits food intake and is typically recommended for patients who are unable to lose weight on their own through diet and exercise.

Direct Flow Medical has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the pivotal phase of the SALUS trial. The SALUS trial is a prospective, non-randomized, multicenter, core lab adjudicated clinical trial, evaluating the Direct Flow Medical transcatheter aortic valve system at up to 30 sites.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now